GlaxoSmithKline PLC Investor Science Event: ASN Kidney Week Transcript - Thomson StreetEvents

GlaxoSmithKline PLC Investor Science Event: ASN Kidney Week Transcript

GlaxoSmithKline PLC Investor Science Event: ASN Kidney Week Transcript - Thomson StreetEvents
GlaxoSmithKline PLC Investor Science Event: ASN Kidney Week Transcript
Published Nov 07, 2021
19 pages (14185 words) — Published Nov 07, 2021
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of GSK.L corporate analyst meeting

  
Brief Excerpt:

...Mick Readey Thank you very much, and good afternoon, and good evening, and welcome to GSK's Investor Science Event Getting Ahead of Anemia from Chronic Kidney Disease for investors and analysts from the American Society of Nephrology Kidney Week 2021. I'm Mick Readey, your moderator for today's call and a member of the GSK IR Team. We're here today for an update on daprodustat, a potential best-in-class new medicines for the treatment of anemia of chronic kidney disease. As usual, the presentation materials are available on gsk.com and were sent to our distribution list earlier today. Please also note that the data presented on today's call are available on the ASN website or in the accompanying publication on the New England Journal of Medicine. Before we get started, I would like to thank Frannie DeFranco from the IR team for her contribution to today's call. Please turn to Slide 2. Now a quick reminder of the usual safe harbor statement and forward-looking statements disclaimer. Please...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
GlaxoSmithKline PLC
Ticker
GSK.L
Time
5:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Kerry Ann Holford - Joh. Berenberg, Gossler & Co. KG, Research Division - Analyst : One for me. So on commercial infrastructure, Luke, you mentioned you would leverage your Benlysta position. Should we expect any significant incremental spend required to launch dapro, assuming it's approved? And can I ask for clarification on the number of reps you mentioned, I think it was 900. Are those already on board promoting Benlysta or is that the total you will need to then increase to? And my second question is just on the rate of increase in hemoglobin. So you referenced what I saw in the paper a faster increase in hemoglobin noted in the dialysis trial versus ESA between the first 4 weeks of therapy. Is that an important differentiated point in the clinic, do you expect that to work in your favor in discussions with regulators? Or are there, in fact, any potential risks associated with such rapid change in hemoglobin?

Table Of Contents

GlaxoSmithKline PLC to Discuss About Investing in Healthcare Innovations: A Case Study of Multi-stakelholder Capitalism in Practice Call Transcript – 2022-02-10 – US$ 54.00 – Edited Transcript of GSK.L conference call or presentation 10-Feb-22 1:00pm GMT

GlaxoSmithKline PLC Q4 2021 Earnings Call Transcript – 2022-02-09 – US$ 54.00 – Edited Transcript of GSK.L earnings conference call or presentation 9-Feb-22 2:00pm GMT

GlaxoSmithKline PLC at JPMorgan Healthcare Conference (Virtual) Transcript – 2022-01-11 – US$ 54.00 – Edited Transcript of GSK.L presentation 11-Jan-22 12:30pm GMT

GlaxoSmithKline PLC at Goldman Sachs Healthcare CEOs Unscripted Conference: A View from the Top (Virtual) Transcript – 2022-01-06 – US$ 54.00 – Edited Transcript of GSK.L presentation 6-Jan-22 1:00pm GMT

GlaxoSmithKline PLC Meet GSK Management: Getting Ahead of HIV Transcript – 2021-11-29 – US$ 54.00 – Edited Transcript of GSK.L corporate analyst meeting</ 29-Nov-21 3:00pm GMT

GlaxoSmithKline PLC Q3 2021 Earnings Call Transcript – 2021-10-27 – US$ 54.00 – Edited Transcript of GSK.L earnings conference call or presentation 27-Oct-21 1:00pm GMT

GlaxoSmithKline PLC at Guggenheim Vaccine and Infectious Disease Conference (Virtual) Transcript – 2021-10-06 – US$ 54.00 – Edited Transcript of GSK.L presentation 6-Oct-21 5:00pm GMT

GlaxoSmithKline PLC at Citi BioPharma Conference (Virtual) Transcript – 2021-09-09 – US$ 54.00 – Edited Transcript of GSK.L presentation 9-Sep-21 5:25pm GMT

GlaxoSmithKline PLC Q2 2021 Earnings Call Transcript – 2021-07-28 – US$ 54.00 – Edited Transcript of GSK.L earnings conference call or presentation 28-Jul-21 1:00pm GMT

GlaxoSmithKline PLC Investor Update Transcript – 2021-06-23 – US$ 54.00 – Edited Transcript of GSK.L corporate analyst meeting</ 23-Jun-21 1:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "GlaxoSmithKline PLC Investor Science Event: ASN Kidney Week Transcript" Nov 07, 2021. Alacra Store. May 04, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/GlaxoSmithKline-PLC-Investor-Science-Event-ASN-Kidney-Week-T15010394>
  
APA:
Thomson StreetEvents. (2021). GlaxoSmithKline PLC Investor Science Event: ASN Kidney Week Transcript Nov 07, 2021. New York, NY: Alacra Store. Retrieved May 04, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/GlaxoSmithKline-PLC-Investor-Science-Event-ASN-Kidney-Week-T15010394>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.